Contract facts
FederalNo full NAICS 541712 intel page yet. Browse NAICS intelligence
Nichd: R&D: Clinical Treatment of Nestorone Gel and Testosterone Gel for Male Contraception: Non-Severable is a federal award for National Institutes Of Health Nichd held by Oregon Health & Science University. Estimated value $12M ($5.8M obligated). Current period of performance ends Dec 31, 2026. Last award drew 3 bidders. Place of performance: PORTLAND OR. Related solicitation NIHNICHDCRHB201204.
Nichd: r&d: clinical treatment of nestorone gel and testosterone gel for male contraception: non-severable. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (71 days remaining). Agencies typically plan 12–18 months ahead — at 2.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on HHSN27500007? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOregon Health & Science University — $69.0M obligated across 216 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HHSN27500007?
HHSN27500007 (Nichd: r&d: clinical treatment of nestorone) is a National Institutes Of Health Nichd award with a potential value of $12M, currently held by Oregon Health & Science University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HHSN27500007?
National Institutes Of Health Nichd awarded HHSN27500007 to Oregon Health & Science University (potential $12M).
Who is the incumbent on HHSN27500007?
Oregon Health & Science University is the incumbent with $69.0M across 216 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Oregon Health & Science University’s HHSN27500007 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HHSN27500007? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.